Antibiotic Management
|
Received Pre-ED/UC PO antibiotics – n (%)
|
49 (45)
| |
Days of OPAT IV - median (IQR)
|
3 [2]
| |
Days of Post-OPAT PO – median (IQR)
|
9 [3]
| |
Total OPAT & Post-OPAT days – median (IQR)
|
15 [4]
| |
Antibiotic Regime – n (%)
|
ED/UC prescription (IV) (n = 105)
|
Cefazolin & metronidazoleb
|
60 (57)
| |
Clindamycinc
|
22 [21]
| |
Ceftriaxone & metronidazoleb
|
13 [12]
| |
Other
|
10 [10]
| |
OPAT prescription (IV) (n = 108)
|
Cefazolin & metronidazoleb
|
84 (78)
| |
Ceftriaxone & metronidazoleb
|
14 [13]
| |
Clindamycinc
|
10 [9]
| |
OPAT discharge prescription (PO) (n = 107)
|
Cephalexin or cefadroxil both with metronidazole
|
64 (60)
| |
Amoxicillin-clavulanic acid
|
24 [22]
| |
Clindamycinc
|
16 [15]
| |
Other
|
3 [3]
| |
Regime Specific Duration of Antibiotics – days
|
Parenteral (IV)g
| |
p = 0.2
|
Narrow spectrum IV regime – mean (SD)d
|
4.2 (2.2)
| |
Broad spectrum IV regime – mean (SD)e
|
3.2 (1.1)
| |
Total course (IV & PO) (n = 107)
| |
p = 0.4
|
Narrow spectrum regimef – mean (SD)
|
14.9 (4.3)
| |
Broad spectrum regime# – mean (SD)
|
15.2 (5.4)
| |